HIT Consultant October 3, 2023 Read the full article >> What You Should Know: – OM1, a real-world data, AI, and technology company with a focus on chronic diseases launches two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. – Both datasets are derived from longitudinal follow-ups of patients seen by specialists and focus on patient[…]
Dermatology Times October 3, 2023 Read the full article >> OM1, a real-world data and AI technology company, recently announced the continued expansion of its Dermatology Network to now include hidradenitis suppurativa (HS), adding approximately 26,000 new patient records to its database. The addition of the HS database will help find innovative solutions and improve health outcomes[…]
Dermatology Times October 3, 2023 Read the full article on pages 32 and 33 >> Artificial intelligence (AI) has been a buzzword in health care for some time, but do clinicians, especially in dermatology, view it as friend or foe? Applications and use of AI in dermatology are comparatively new and have focused primarily on[…]
Business Wire October 2, 2023 Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, AI, and technology company with a focus on chronic diseases, announced the launch of two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. Both datasets are derived from longitudinal follow-up of patients seen by specialists and focus on patient characteristics, symptoms,[…]
Practical Dermatology September 22, 2023 Read the full article >> OM1 is expanding its Dermatology Network to include almost 26,000 hidradenitis suppurativa (HS) patient records. “HS patients benefit when all available information on their journey can be surfaced and used to improve care and decision-making,” Joseph Zabinski tells DermWire. He is the Managing Director of AI and Personalized Medicine at OM1. “Much of this[…]
